A RANDOMIZED DOUBLE-BLIND TRIAL IN 813 PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER (CAP) PATIENTS (PTS) COMPARING A NEW ANTIANDROGEN CASODEX(R) (BICALUTAMIDE) WITH EULEXIN (FLUTAMIDE) IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG (LHRH-A) THERAPY
Nj. Vogelzang et al., A RANDOMIZED DOUBLE-BLIND TRIAL IN 813 PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER (CAP) PATIENTS (PTS) COMPARING A NEW ANTIANDROGEN CASODEX(R) (BICALUTAMIDE) WITH EULEXIN (FLUTAMIDE) IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG (LHRH-A) THERAPY, European journal of cancer, 31A, 1995, pp. 456-456